๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

53LBA A phase I/IIa study of icotinib hydrochloride (BPI-2009H), an oral epidermal growth factor receptor tyrosine kinases inhibitor, in patients with advanced non-small-cell lung cancer and other solid tumors

โœ Scribed by Q. Zhao; J. Zhou; J. Shentu; L. Wu; N. Xu; F. Tan; Y. Wang; D. Yang


Book ID
119600830
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
47 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase I and pharmacokinetic study of d